查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
输血诊断市场规模、份额、趋势分析报告：按产品、按用途、按最终用途、按地区、细分趋势，2023-2030
市场调查报告书
商品编码
1321327

输血诊断市场规模、份额、趋势分析报告：按产品、按用途、按最终用途、按地区、细分趋势，2023-2030

Blood Transfusion Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents & Kits), By Application, By End-use (Hospitals, Blood Banks), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

输血诊断市场增长和趋势

Grand View Research, Inc.最新报告显示，2023年至2030年，全球输血诊断市场规模预计将以5.8%的复合年复合成长率增长，2030年将达到69.6亿美元。

输血诊断测试是在输血前对血液及其成分进行的筛查测试，以确保不会将感染疾病传播给患者。贫血和血小板减少症等血液相关疾病的发病率不断增加，增加了输血的需求。例如，世界卫生组织2023年6月发布的估计显示，在低收入国家，近54%的输血需要5岁以下儿童，而高所得国家则需要76%的输血。适合 60 岁以上的成年人。患者人数和血液需求的增加预计也将推动市场增长。

此外，不同国家正在采取多项倡议来组织和促进捐血活动，从而提高人们对捐血的认识。评估血液相容性并确保其尚未被感染至关重要，因此预计将推动市场增长。这些措施还有助于早期发现和治疗各种疾病，特别是在输血感染疾病常见的发展中国家。此外，由于技术进步、政府倡议以及研发投资增加等其他因素，预计该市场也会增长。

COVID-19 大流行对输血诊断行业产生了重大影响。由于人员流动受到限制，捐血活动被取消，对捐血人数产生了负面影响。例如，根据 PubMed 2021 年 11 月发布的一项研究，在 COVID-19 疫情期间，捐血率下降了 40% 至 67%。

疫情还扰乱了全球供应链，影响了这些诊断测试所需的医疗设备的生产和分配，因为重点已转向减轻 COVID-19 本身的影响。然而，随着法规的放鬆，许多国家实施了创新活动来鼓励捐血。例如，根据世界卫生组织（WHO）2021年6月发表的报导，乌干达输血服务中心（UBTS）已经建立了呼叫中心，并正在利用各种社交媒体平台来接触更多的捐赠者。我们还创建了捐赠者招募用途。

输血诊断市场报告亮点

  • 按产品划分，试剂和试剂盒细分市场在 2022 年占据最大的销售份额。这是因为它很容易获得併且可以重复购买以进行捐赠者筛选。
  • 由于意识的提高，捐赠者和筛查数量不断增加，预计试剂和试剂盒部分也将在预测期内以最快的速度增长。
  • 从用途来看，疾病筛查领域在2022年占据了最大的销售份额。输血感染疾病的增加要求进行更多筛查，以避免受血者出现并发症。
  • 在最终用途领域，血库将在 2022 年占据市场主导地位。该领域的增长是由于血液相关疾病的患病率不断增加以及随之而来的血液筛查需求。
  • 2022 年，由于该地区的意识不断提高和可支配收入显着，北美在收入份额方面占据了市场主导地位。与此同时，由于捐血感染疾病的流行和献血意识的提高，预计亚太地区在预测期内将以最快的年复合成长率增长。

目录

第1章调查方法和范围

  • 市场区隔和范围
  • 调查方法
  • 资讯采购
  • 资讯或资料分析
  • 市场形成和检验
  • 型号详情
  • 二手资讯清单
  • 主要资讯清单
  • 目的

第2章执行摘要

第3章输血诊断市场变量、趋势、范围

  • 市场体系预测
    • 母公司市场预测
    • 相关/附市场预测
  • 采用和增长预测
  • 行业价值链分析
    • 赎回框架
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 输血诊断市场分析工具
    • 行业分析-波特
    • PESTEL分析

第4章输血诊断：产品估算和趋势分析

  • 输血诊断市场：关键要点
  • 输血诊断市场：2022 年和 2030 年趋势和市场份额分析
  • 试剂/试剂盒
  • 设备
  • 其他的

第5章输血诊断：用途估计和趋势分析

  • 输血诊断市场：关键要点
  • 输血诊断市场：2022 年和 2030 年趋势和市场份额分析
  • 血型测定
  • 疾病筛查

第6章输血诊断：最终用途估计和趋势分析

  • 输血诊断市场：关键要点
  • 输血诊断市场：2022 年和 2030 年趋势和市场份额分析
  • 医院
  • 血库
  • 诊断实验室
  • 其他的

第7章输血诊断市场：区域估计和趋势分析

  • 区域预测
  • 按地区分列的输血诊断市场：市场亮点
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 鲷鱼
    • 韩国
  • 拉美
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙特阿拉伯
    • 南非
    • 阿拉伯联合酋长国
    • 科威特

第8章竞争形势

  • 主要市场参与企业的最新发展和影响分析
  • 市场参与企业分类
    • Grifols
    • Bio-Rad Laboratories, inc.
    • F.Hoffman-La Roche AG
    • Quotient Limited
    • Abbott
    • Ortho Clinical Diagnostics
    • BIOMERIEUX
    • Siemens Healthcare Private Limited
    • MedGenome
    • Beckman Coulter
Product Code: GVR-4-68038-855-8

Blood Transfusion Diagnostics Market Growth & Trends

The global blood transfusion diagnostics market size is expected to reach USD 6.96 billion by 2030, expanding at 5.8% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. Blood transfusion diagnostics tests are screening tests performed on blood and its components before transfusion to ensure no infections are transmitted to the patient. An increase in the incidence of several blood-related diseases such as anemia and thrombocytopenia is driving the need for blood transfusion. For instance, according to the estimates of WHO released in June 2023, nearly 54% of total blood transfusions are needed for children below five years of age in low-income countries whereas 76% of total transfusions in high-income countries are needed for adults over 60 years of age. The increase in the patient group and blood requirement is also expected to drive market growth.

Moreover, there is an increased awareness regarding blood donation owing to several initiatives taken to organize and promote blood drives across countries. It is expected to drive market growth as it is essential to assess the compatibility of blood and ensure it is not already infected. Such steps also help in the early detection and treatment of various diseases, especially among less developed countries where the frequency of transfusion-transmitted diseases is higher. Furthermore, the market is expected to grow owing to several other factors such as technological advancements, government initiatives, and increasing investment in research and development.

The COVID-19 pandemic had a significant impact on the blood transfusion diagnostics industry. Since there were restrictions on people's movement, it led to the cancellation of blood drives and negatively impacted the number of blood donations. For instance, according to a study published by PubMed in November 2021, the ratio of blood donation decreased by 40% to 67% during the COVID-19 outbreak.

The pandemic also disrupted global supply chains, which affected the production and distribution of medical devices needed for these diagnostics tests since the majority of focus was devoted to reducing the impact of COVID-19 itself. However, many countries organized innovative campaigns to encourage blood donations as restrictions were eased. For instance, in an article published by the World Health Organization in June 2021, Uganda Blood Transfusion Service (UBTS) created a call center, used various social media platforms to reach out to more donors, and an application was also created to recruit donors.

Blood Transfusion Diagnostics Market Report Highlights

  • Based on product, the reagents & kits segment accounted for the largest revenue share in 2022, owing to their availability and repetitive purchases for the screening of donors
  • The reagents & kits segment is also expected to grow at the fastest rate during the forecast period, as the number of donors and screenings increase with increasing awareness
  • Based on application, the disease screening segment accounted for the largest revenue share in 2022, as an increase in the transfusion-transmitted infection demands more screenings to avoid any complications to the receiver
  • In the end-use segment, blood banks dominated the market in 2022. The growth of this segment can be attributed to the increasing prevalence of blood-related diseases and subsequently, the need for blood screening derived from it
  • In 2022, North America dominated the market in terms of revenue share owing to increasing awareness and notable disposable income in the region. On the other hand, Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period due to the prevalence of transfusion-transmitted diseases and growing awareness regarding blood donation

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. End-use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5 Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Blood Transfusion Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. The increasing prevalence of chronic diseases
      • 3.4.1.2. Rising demand for donor screening
      • 3.4.1.3. Rising number of road & trauma accident cases and surgeries
      • 3.4.1.4. Growing initiatives for blood donation campaigns
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Lack of sufficient blood donations as compared to demand.
  • 3.5. Blood Transfusion Diagnostics Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. The threat of new entrants
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape

Chapter 4. Blood Transfusion Diagnostics: Product Estimates & Trend Analysis

  • 4.1. Blood Transfusion Diagnostics Market: Key Takeaways
  • 4.2. Blood Transfusion Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Reagents & kits
    • 4.3.1. Reagents & kits market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Blood Transfusion Diagnostics: Application Estimates & Trend Analysis

  • 5.1. Blood Transfusion Diagnostics Market: Key Takeaways
  • 5.2. Blood Transfusion Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Blood Grouping
    • 5.3.1. Blood grouping market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Disease Screening
    • 5.4.1. Disease screening estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.2. Serological disease screening
      • 5.4.2.1. Blood transfusion diagnostics market for serological disease screening estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.3. Molecular disease screening
      • 5.4.3.1. Blood transfusion diagnostics market for molecular disease screening

Chapter 6. Blood Transfusion Diagnostics: End-use Estimates & Trend Analysis

  • 6.1. Blood Transfusion Diagnostics Market: Key Takeaways
  • 6.2. Blood Transfusion Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Hospitals
    • 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Blood Banks
    • 6.4.1. Blood banks market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Diagnostic Laboratories
    • 6.5.1. Diagnostics laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Blood Transfusion Diagnostics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Blood Transfusion Diagnostics Market by Region: Key Marketplace Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. Saudi Arabia
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Grifols
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Bio-Rad Laboratories, inc.
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. F.Hoffman-La Roche AG
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Quotient Limited
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Abbott
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Ortho Clinical Diagnostics
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. BIOMERIEUX
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Siemens Healthcare Private Limited
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. MedGenome
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Beckman Coulter
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America blood transfusion diagnostics market, by End-use, 2018 - 2030 (USD Million)
  • Table 5 North America blood transfusion diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 13 Europe blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 14 Europe blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe blood transfusion diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 17 Germany blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 23 France blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 24 France blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Sweden blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 32 Sweden blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 33 Sweden blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Norway blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 35 Norway blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 36 Norway blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Denmark blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 38 Denmark blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 39 Denmark blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific blood transfusion diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 44 China blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 45 China blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 46 China blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Japan blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 48 Japan blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 49 Japan blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 India blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 51 India blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 52 India blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Thailand blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 54 Thailand blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 55 Thailand blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 South Korea blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Korea blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Latin America blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 60 Latin America blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 61 Latin America blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America blood transfusion diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 63 Brazil blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 64 Brazil blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 65 Brazil blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Mexico blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 67 Mexico blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 68 Mexico blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Argentina blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 70 Argentina blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 71 Argentina blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Middle East and Africa blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 73 Middle East and Africa blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 74 Middle East and Africa blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa blood transfusion diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 76 South Africa blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 77 South Africa blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 78 South Africa blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 UAE blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 83 UAE blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 84 UAE blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 Kuwait blood transfusion diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 86 Kuwait blood transfusion diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 87 Kuwait blood transfusion diagnostics market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Blood transfusion diagnostics: market outlook
  • Fig. 9 Blood transfusion diagnostics competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Blood transfusion diagnostics market driver impact
  • Fig. 15 Blood transfusion diagnostics market restraint impact
  • Fig. 16 Blood transfusion diagnostics market Strategic initiatives analysis
  • Fig. 17 Blood transfusion diagnostics market: Product movement analysis
  • Fig. 18 Blood transfusion diagnostics market: Product outlook and key takeaways
  • Fig. 19 Reagents & kits market estimates and forecasts, 2018 - 2030
  • Fig. 20 Instruments market estimates and forecasts, 2018 - 2030
  • Fig. 21 Others market estimates and forecasts, 2018 - 2030
  • Fig. 22 Blood transfusion diagnostics market: Application movement analysis
  • Fig. 23 Blood transfusion diagnostics market: Application outlook and key takeaways
  • Fig. 24 Blood grouping market estimates and forecasts, 2018 - 2030
  • Fig. 25 Disease screening market estimates and forecasts, 2018 - 2030
  • Fig. 26 Blood transfusion diagnostics market: End-use movement analysis
  • Fig. 27 Blood transfusion diagnostics market: End-use outlook and key takeaways
  • Fig. 28 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 29 Blood banks market estimates and forecasts, 2018 - 2030
  • Fig. 30 Diagnostic laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 31 Others market estimates and forecasts, 2018 - 2030
  • Fig. 32 Global blood transfusion diagnostics market: Regional movement analysis
  • Fig. 33 Global blood transfusion diagnostics market: Regional outlook and key takeaways
  • Fig. 34 North America market estimates and forecasts, 2018 - 2030
  • Fig. 35 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 36 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 37 Europe. market estimates and forecasts, 2018 - 2030
  • Fig. 38 UK market estimates and forecasts, 2018 - 2030
  • Fig. 39 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 40 France market estimates and forecasts, 2018 - 2030
  • Fig. 41 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 42 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 43 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 44 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 45 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 46 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 47 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 48 China market estimates and forecasts, 2018 - 2030
  • Fig. 49 India market estimates and forecasts, 2018 - 2030
  • Fig. 50 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 51 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 52 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 53 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 54 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 55 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 56 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 57 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 58 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 59 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 60 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 61 Kuwait market estimates and forecasts, 2018 - 2030